Volume 9, Issue 35 (Summer 2011)                   ASJ 2011, 9(35): 130-136 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mohammadzadeh F, Mehdizadeh M, Alizadeh A, Farahani Pad R, Kermanian F, Soleimani Asl S, et al . The Role of Agonist of A2a Adenosine Receptors on Neurotoxicity of Mdma (Ecstasy Pill) on Rat’S Hippocampus. ASJ 2011; 9 (35) :130-136
URL: http://anatomyjournal.ir/article-1-532-en.html
Abstract:   (755 Views)
Purpose: MDMA is a synthetic drug that is originated from Amphetamine. It is used by some people. This material induces some chemical changes in serotonergic and dopaminergic neurons in middle brain. Materials and Methods: In this study, we used 49 Rats Sprague-Dawley, 200-250 gr. There were 7 groups and 7 Rats in each group. Rats received MDMA in the first group, in the second group CGS (A2A receptor agonist), in the third group SCH (A2A receptor Antagonist), group 4 vehicle for CGS and SCH, group5 vehicle for ecstasy, in 6th group MDMA with CGS, in 7th group MDMA with SCH. All groups received drugs ip, daily for 7 days. Then we took out some Hippocampus samples after perfusion in order to investigate apoptosis. These samples were stained with tunnel kit, and studied by light microscope. In some other rats, we removed fresh tissue and studied the expression of BAX and BCL-2 proteins by western blotting.Result: The results of this study showed that the usage of MDMA with CGS reduced the BAX protein expression and protected apoptosis of Hippocampus cells. The usage of MDMA with SCH increased the BAX protein expression and number of apoptotic Hippocampus cells.Conclusion: The results of our study indicated that CGS with MDMA decreased the side effects of the usage of MDMA
Full-Text [PDF 399 kb]   (431 Downloads)    
Type of Study: Original | Subject: Morphometry
Received: 2021/12/30 | Accepted: 2011/08/28 | Published: 2011/08/28

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb